CD4+FoxP3+regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo

被引:174
作者
Grauer, Oliver M.
Nierkens, Stefan
Bennink, Erik
Toonen, Liza W. J.
Boon, Louis
Wesseling, Pieter
Sutmuller, Roger P. M.
Adema, Gosse J.
机构
[1] Radboud Univ Nijmegen, Med Ctr, Tumor Immunol Lab, Dept Tumor Immunol,Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands
[2] Univ Regensburg, Dept Neurol, D-8400 Regensburg, Germany
[3] Bioceros BV, Utrecht, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Dept Pathol, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands
关键词
glioma; regulatory T cell; immune escape;
D O I
10.1002/ijc.22607
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The suppressive activity of regulatory T cells (Treg) has been implicated as an important factor limiting immune mediated destruction of tumor cells. However, not much is known about the presence and function of Treg within tumors. Here we show in a syngeneic murine glioma model a time-dependent accumulation of CD4+FoxP3+ Treg in brain tumors. Further analysis revealed a time-dependent upregulation of CD25, CTLA-4, GITR and CXCR4 on intratumoral CD4+FoxP3+ Treg during tumor growth. Moreover, freshly isolated intratumoral Treg were highly suppressive when tested directly ex vivo. Treatment with anti-CD25 monoclonal antibodies (mAbs) significantly reduced the number of these highly suppressive CD4+FoxP3+ cells within the growing tumor and provoked a CD4 and CD8 T cell dependent destruction of the glioma cells. Combining Treg depletion with administration of blocking CTLA-4 mAbs further boosted glioma-specific CD4+ and CD8+ effector T cells as well as antiglioma IgG2a antibody titers resulting in complete tumor eradication without any signs of autoimmunity. These data illustrate that intratumoral accumulation and activation of CD4+FoxP3+ Treg act as a dominant immune escape mechanism for gliomas and underline the importance of controlling tumor- infiltrating Treg in glioma immunotherapy. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:95 / 105
页数:11
相关论文
共 50 条
  • [1] Homeostasis of peripheral CD4+ T cells:: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers
    Almeida, ARM
    Legrand, N
    Papiernik, M
    Freitas, AA
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (09) : 4850 - 4860
  • [2] Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
    Attia, P
    Phan, GQ
    Maker, AV
    Robinson, MR
    Quezado, MM
    Yang, JC
    Sherry, RM
    Topalian, SL
    Kammula, US
    Royal, RE
    Restifo, NP
    Haworth, LR
    Levy, C
    Mavroukakis, SA
    Nichol, G
    Yellin, MJ
    Rosenberg, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6043 - 6053
  • [3] BERNARD CCA, 1976, J IMMUNOGENET, V3, P263
  • [4] Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
    Caramalho, I
    Lopes-Carvalho, T
    Ostler, D
    Zelenay, S
    Haury, M
    Demengeot, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) : 403 - 411
  • [5] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949
  • [6] An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
    El Andaloussi, Abdejabar
    Lesniak, Maciej S.
    [J]. NEURO-ONCOLOGY, 2006, 8 (03) : 234 - 243
  • [7] Cutting edge:: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7
    Fantini, MC
    Becker, C
    Monteleone, G
    Pallone, F
    Galle, PR
    Neurath, MF
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (09) : 5149 - 5153
  • [8] Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
    Fecci, PE
    Mitchell, DA
    Whitesides, JF
    Xie, WH
    Friedman, AH
    Archer, GE
    Herndon, JE
    Bigner, DD
    Dranoff, G
    Sampson, JH
    [J]. CANCER RESEARCH, 2006, 66 (06) : 3294 - 3302
  • [9] Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells
    Fehérvári, Z
    Sakaguchi, S
    [J]. INTERNATIONAL IMMUNOLOGY, 2004, 16 (12) : 1769 - 1780
  • [10] A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
    Fontenot, JD
    Rudensky, AY
    [J]. NATURE IMMUNOLOGY, 2005, 6 (04) : 331 - 337